Stifel Reiterates Hold Rating on ALX Oncology (ALXO)

December 18, 2024 9:13 AM EST Send to a Friend
Stifel analyst Bradley Canino reiterated a Hold rating and $3.00 price target on ALX Oncology (NASDAQ: ALXO).The analyst said: "Results ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login